ASCEND BY NTHRYS
Research Abroad Products

Pharmacology Project Topics

Browse all focused areas across all project categories under this field.

Showing 157–168 of 210 project topics
Patient Outcome Prediction Engine for Personalized Inflammation Treatment
An AI-driven decision support tool that predicts patient response to specific anti-inflammatory therapies based on genetic, biomarker, and clinical data profiles. This enables companion diagnostic revenue of $50-200 per patient while supporting precision medicine claims and improved clinical outcomes.
Inflammation Pharmacology Drug Development Click to view more details →
Contract Research Manufacturing Optimization Platform for Biologic Production
A digital platform that optimizes manufacturing processes, batch analytics, and quality control for inflammation-targeting biologics produced by CDMO partners. This generates subscription and per-batch revenue of $2-8M annually while improving yields and reducing manufacturing variability.
Inflammation Pharmacology Drug Development Click to view more details →
Scientific Literature Mining Tool for Inflammation Drug Target Discovery
An NLP-powered SaaS tool that mines published research and patents to identify emerging inflammation targets, mechanism insights, and clinical trial landscape trends. This generates $250K-600K annual licensing revenue while supporting portfolio decisions and early-stage target validation.
Inflammation Pharmacology Drug Development Click to view more details →
Digital Health Platform for Remote Inflammation Patient Monitoring and Adherence
A mobile and cloud platform that enables remote symptom tracking, medication adherence monitoring, and real-world evidence collection for inflammation patients on pharmaceutical therapies. This creates recurring SaaS revenue of $500K-2M annually while generating real-world evidence that supports post-market claims and patient retention.
Inflammation Pharmacology Drug Development Click to view more details →
AI-Powered Hormone Receptor Binding Prediction Platform
A machine learning platform that predicts binding affinities between drug candidates and endocrine receptors using advanced neural networks and structural biology databases. This accelerates drug discovery timelines and reduces failed clinical trials, generating licensing revenue and improving R&D ROI for pharmaceutical companies.
Endocrine Pharmacology Drug Design Platforms Click to view more details →
Cloud-Based Insulin Analog Structure Optimization SaaS
A cloud software platform enabling rapid in silico design and optimization of insulin analogs with customized pharmacokinetic properties for different patient populations. The platform generates revenue through subscription licensing to insulin manufacturers and biotech firms seeking faster market entry for novel formulations.
Endocrine Pharmacology Drug Design Platforms Click to view more details →
Thyroid Hormone Metabolism Simulation and Prediction Engine
An integrated computational tool that simulates thyroid hormone metabolism, clearance, and tissue distribution using pharmacokinetic modeling and physiologically-based simulations. This enables development of thyroid replacement therapies with improved dosing regimens, supporting market differentiation and premium pricing for next-generation TSH-control products.
Endocrine Pharmacology Drug Design Platforms Click to view more details →
High-Throughput Estrogen Receptor Screening Automation Platform
An automated laboratory platform combining robotics, microfluidics, and real-time assay analytics for rapid screening of estrogenic compound activity and selectivity. This generates revenue through equipment sales, consumables, and service contracts while reducing pharmaceutical clients'' compound validation costs by 60-70 percent.
Endocrine Pharmacology Drug Design Platforms Click to view more details →
GLP-1 Agonist Peptide Drug Design and Sequence Optimization
A specialized software suite for designing and optimizing GLP-1 receptor agonist peptides with enhanced stability, bioavailability, and reduced immunogenicity through computational sequence analysis. The platform captures market share in the high-growth diabetes market by enabling rapid development of differentiated products with premium pricing potential.
Endocrine Pharmacology Drug Design Platforms Click to view more details →
Corticosteroid Receptor Selectivity Profiling and Prediction Tool
A computational platform predicting glucocorticoid and mineralocorticoid receptor selectivity profiles to design steroids with improved therapeutic windows and reduced side effects. This enables development of next-generation corticosteroids with lower adverse event rates, creating opportunities for premium market positioning and licensing deals with major pharma.
Endocrine Pharmacology Drug Design Platforms Click to view more details →
Sex Hormone Metabolism and Drug Interaction Modeling Platform
An integrated pharmacokinetic-pharmacodynamic modeling system simulating estrogen, testosterone, and progesterone metabolism alongside drug interactions for HRT and contraceptive development. This reduces clinical trial failures and enables targeted development for specific patient subpopulations, supporting premium pricing and regulatory approval acceleration.
Endocrine Pharmacology Drug Design Platforms Click to view more details →
PPAR Agonist Selectivity Design and Off-Target Risk Assessment
A specialized design platform enabling rational development of selective PPAR agonists while predicting and mitigating off-target cardiotoxicity and adverse effects using integrated computational models. This reduces development risk and clinical failures, allowing faster time-to-market for diabetes and metabolic disease therapeutics with improved safety profiles.
Endocrine Pharmacology Drug Design Platforms Click to view more details →